Summit Securities Group’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,300
Closed -$324K 1257
2022
Q2
$324K Buy
+4,300
New +$191K 0.04% 240